Contact
Please use this form to send email to PR contact of this press release:
Soricimed's SOR-C13 Granted Orphan Drug Designation for Pancreatic Cancer by the U.S. FDA
TO:
Please use this form to send email to PR contact of this press release:
Soricimed's SOR-C13 Granted Orphan Drug Designation for Pancreatic Cancer by the U.S. FDA
TO: